Pharmacokinetic study of the interaction between itraconazole and nevirapine.

Abstract:

OBJECTIVE:To investigate the drug interaction potential between itraconazole and nevirapine. METHODS:Our study was conducted in 12 healthy volunteers in two phases. In phase 1 (from days 1-28), all subjects were randomly assigned to a two-way crossover study of a nevirapine regimen (nevirapine 200 mg once daily for 7 days) and an itraconazole regimen (itraconazole 200 mg once daily for 7 days) with a 14-day wash-out period between. Phase 2 (from days 43-49) was performed 14 days after phase 1 ended, and all subjects received a combination regimen (nevirapine 200 mg combined with itraconazole 200 mg once daily for 7 days). Nevirapine pharmacokinetic studies were carried out starting with the seventh dose of nevirapine in the nevirapine regimen (on days 7-10 or 28-31) and the combination regimen (on days 49-52). Itraconazole pharmacokinetic studies were carried out starting with the seventh dose of itraconazole in the itraconazole regimen (on days 7-10 or 28-31) and the combination regimen (on days 49-52). RESULTS:There was no significant difference in nevirapine pharmacokinetic parameters between the nevirapine and combination regimens. Itraconazole plasma concentrations were lower when it was administered in the combination regimen than when it was administered in the itraconazole regimen. The mean C(max), AUC(0-96) and t (1/2) of itraconazole were significantly reduced by 38, 61 and 31%, respectively. CONCLUSION:Nevirapine had a strong inducing effect on the metabolism of itraconazole, but there was no significant effect of itraconazole on the pharmacokinetics of nevirapine. However, a higher daily dosage of itraconazole might have an inhibitory effect.

journal_name

Eur J Clin Pharmacol

authors

Jaruratanasirikul S,Sriwiriyajan S

doi

10.1007/s00228-007-0280-x

subject

Has Abstract

pub_date

2007-05-01 00:00:00

pages

451-6

issue

5

eissn

0031-6970

issn

1432-1041

journal_volume

63

pub_type

杂志文章,随机对照试验
  • Differences in the bioavailability of dihydrotachysterol preparations.

    abstract::The bioavailability of four preparations containing dihydrotachysterol (DHT2) was tested in two separate trials with administration of single, oral doses of 1 mg per individual. The relative bioavailability of corresponding preparations (capsules vs capsules and oral solution vs oral solution) was tested in a randomis...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/BF00193484

    authors: Koytchev R,Alken RG,Vagaday M,Kunter U,Kirkov V

    更新日期:1994-01-01 00:00:00

  • Haemodynamic effects of combined oral nifedipine and sublingual nitroglycerin in patients with chronic stable angina.

    abstract::We examined the pharmacokinetics of nifedipine after acute and sustained oral therapy and the potential haemodynamic interaction between nifedipine and sublingual nitroglycerin in nine patients with chronic stable angina. Nifedipine pharmacokinetics after a single oral dose and sustained dosing (three times daily for ...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/BF00637629

    authors: Boje KM,Fung HL,Yoshitomi K,Parker JO

    更新日期:1987-01-01 00:00:00

  • Effects of a new oral hypoglycaemic agent, repaglinide, on metabolic control in sulphonylurea-treated patients with NIDDM.

    abstract::We have evaluated the effects of repaglinide, a new non-sulphonylurea oral hypoglycaemic agent that has a stimulatory effect on insulin secretion. Forty-four patients with NIDDM, already treated with a sulphonylurea, took part in an open, randomised, group comparison study of 12 weeks duration, during which they recei...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/BF00315490

    authors: Wolffenbuttel BH,Nijst L,Sels JP,Menheere PP,Müller PG,Kruseman AC

    更新日期:1993-01-01 00:00:00

  • Altered pharmacokinetics of lignocaine after epidural injection in type II diabetics.

    abstract::The pharmacokinetics of lignocaine has been compared after epidural anaesthesia in diabetics and non-diabetic patients. Epidural lignocaine 8 mg.kg-1 was given to 8 well controlled Type II diabetic and 8 non-diabetic patients and the plasma drug concentration in serial blood samples were measured by HPLC. The plasma l...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF02333021

    authors: Peeyush M,Ravishankar M,Adithan C,Shashindran CH

    更新日期:1992-01-01 00:00:00

  • Children's views on unlicensed/off-label paediatric prescribing and paediatric clinical trials.

    abstract:OBJECTIVES:To explore the views and perspectives of children on the unlicensed/off-label use of medicines in children and on the participation of children in clinical trials. METHODS:Focus-group discussions, involving school children, were carried out in a range of primary and secondary schools in Northern Ireland. A ...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-011-1110-8

    authors: Mukattash T,Trew K,Hawwa AF,McElnay JC

    更新日期:2012-02-01 00:00:00

  • Acute haemodynamic and neurohumoral effects of intravenous nisoldipine in patients with severe congestive heart failure.

    abstract::Twenty patients (5 females, 15 males) with severe heart failure (NYHA IV), due to coronary artery disease in 14, and congestive cardiomyopathy in 6, received an intravenous bolus of the calcium blocker nisoldipine 0.2 mg followed by a continuous infusion of 0.2 micrograms.kg-1.min-1. Haemodynamic measurements were per...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00314795

    authors: Erlemeier HH,Kupper W,Bleifeld W

    更新日期:1990-01-01 00:00:00

  • The effect of fluconazole on the pharmacokinetics of rosuvastatin.

    abstract:OBJECTIVE:To examine the effect of fluconazole, a potent inhibitor of CYP2C9 and CYP2C19, on the pharmacokinetics of rosuvastatin in healthy volunteers. Significantly increased plasma concentrations of fluvastatin have been observed following co-administration with fluconazole. METHODS:This was a randomised, double-bl...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/s00228-002-0508-8

    authors: Cooper KJ,Martin PD,Dane AL,Warwick MJ,Schneck DW,Cantarini MV

    更新日期:2002-11-01 00:00:00

  • Hydralazine-induced lupus: is there a toxic metabolic pathway?

    abstract::The metabolism of hydralazine in a group of slow acetylator patients with the drug-induced lupus syndrome was compared with the metabolism in asymptomatic control subjects. There were no toxicologically significant difference in metabolite excretion between the groups which reached statistical significance, although t...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00556891

    authors: Timbrell JA,Facchini V,Harland SJ,Mansilla-Tinoco R

    更新日期:1984-01-01 00:00:00

  • Effect of grapefruit juice on the pharmacokinetics of tolvaptan, a non-peptide arginine vasopressin antagonist, in healthy subjects.

    abstract:PURPOSE:Tolvaptan is a selective vasopressin V2 receptor antagonist that can be given orally once daily for treatment of clinically significant hypervolemic and euvolemic hyponatremia (US and Europe) or extracellular volume expansion despite taking other diuretics (Japan). In vitro studies indicated that tolvaptan was ...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/s00228-011-1106-4

    authors: Shoaf SE,Mallikaarjun S,Bricmont P

    更新日期:2012-02-01 00:00:00

  • Are systemic levels of non steroidal anti inflammatory drugs relevant to acute upper gastrointestinal haemorrhage?

    abstract::It is uncertain as to the extent which gastrointestinal (GI) haemorrhage related to NSAIDs is due to a local, topical effect or to an action related to systemic absorption. We hypothesised that, should systemic drug concentrations be of importance, plasma levels of NSAIDs might be higher in patients who had developed ...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00316464

    authors: Wynne HA,Rawlins MD

    更新日期:1993-01-01 00:00:00

  • Effects of ketoprofen and ibuprofen on platelet aggregation and prostanoid formation in man.

    abstract:OBJECTIVE:In the present randomized, fourway crossover study we determined the effects of two oral doses each of ketoprofen and ibuprofen on platelet aggregation and prostanoid formation in man. METHODS:Twelve healthy female volunteers received for 2 consecutive days, followed by a 5-day drug-free interval, one of the...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/s002280050189

    authors: Stichtenoth DO,Tsikas D,Gutzki FM,Frölich JC

    更新日期:1996-01-01 00:00:00

  • High prevalence of cytochrome P450 2A6*1A alleles in a black African population of Ghana.

    abstract:OBJECTIVE:We investigated the frequencies of the functionally important variants of the CYP2A6 gene in black African populations. METHODS:Using genomic DNA sequencing, polymerase chain reaction (PCR)-restriction fragment length polymorphism and allele-specific PCR, the allele frequencies of CYP2A6 *1A, *1B, *2, *4A, *...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-004-0854-9

    authors: Gyamfi MA,Fujieda M,Kiyotani K,Yamazaki H,Kamataki T

    更新日期:2005-02-01 00:00:00

  • Enprofylline pharmacokinetics in children with asthma.

    abstract::The pharmacokinetics of intravenous enprofylline has been studied in 8 children with asthma. The mean plasma half-life of enprofylline (1.0 h) was considerably shorter than that previously reported in adults. The half-life determined from log urine excretion rate data was identical to the plasma half-life, so urine ex...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00637683

    authors: Hultqvist C,Borgå O

    更新日期:1987-01-01 00:00:00

  • Frequency of the SLCO1B1 388A>G and the 521T>C polymorphism in Tanzania genotyped by a new LightCycler®-based method.

    abstract:PURPOSE:The 388A>G and the 521T>C polymorphism of the SLCO1B1 gene affect the activity of the uptake transporter OATP1B1, thus influencing kinetics, safety, and efficacy of substrate drugs. To evaluate the impact of these polymorphisms in populations of different ethnic origins, it is important to know their frequencie...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-011-1065-9

    authors: Aklillu E,Mugusi S,Ngaimisi E,Hoffmann MM,König S,Ziesenitz V,Mikus G,Haefeli WE,Weiss J

    更新日期:2011-11-01 00:00:00

  • Oxycodone concentrations are greatly increased by the concomitant use of ritonavir or lopinavir/ritonavir.

    abstract:PURPOSE:this study aimed to investigate the effect of antivirals ritonavir and lopinavir/ritonavir on the pharmacokinetics and pharmacodynamics of oral oxycodone, a widely used opioid receptor agonist used in the treatment of moderate to severe pain. METHODS:a randomized crossover study design with three phases at int...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章,随机对照试验

    doi:10.1007/s00228-010-0879-1

    authors: Nieminen TH,Hagelberg NM,Saari TI,Neuvonen M,Neuvonen PJ,Laine K,Olkkola KT

    更新日期:2010-10-01 00:00:00

  • Comparative lung bioavailability of fluticasone/salmeterol via a breath-actuated spacer and conventional plastic spacers.

    abstract:PURPOSE:This study compares the in vivo relative lung bioavailability of Hydrofluoroalkane (HFA) Seretide delivered via unprimed and unwashed Aerochamber Plus (AP) or Volumatic (VM) spacers, a integrated breath-actuated vortex Synchro-Breathe (SB) device and an Evohaler pMDI (EH) device using adrenal suppression and ea...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章,随机对照试验

    doi:10.1007/s00228-010-0989-9

    authors: Nair A,McKinlay L,Williamson P,Short P,Burns P,Lipworth BJ

    更新日期:2011-04-01 00:00:00

  • Fabry disease and treatment with agalsidase alpha: unsuspected cardiac arrhythmia in two heterozygous women. In reference to pharmacovigilance.

    abstract:CASE REPORTS:Two women treated with agalsidase alpha for Fabry disease developed severe heart dysfunctions a few months after the beginning of enzyme replacement therapy (ERT). An adverse effect caused by the treatment was suspected; therefore we informed the French pharmacovigilance authorities about these two events....

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-007-0460-8

    authors: Mougenot P,Lidove O,Caillaud C,Arnaud P,Papo T

    更新日期:2008-06-01 00:00:00

  • Thyroid hormone concentrations in epileptic patients.

    abstract::Anticonvulsants are associated with decreased serum thyroid hormone concentrations. We have studied thyroid function in 54 epileptic patients on a variety of drugs (19 on carbamazepine, 13 on phenytoin, 10 on sodium valproate, 12 on polypharmacy). For comparison, 14 untreated epileptics and 11 healthy unmedicated volu...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00558149

    authors: Larkin JG,Macphee GJ,Beastall GH,Brodie MJ

    更新日期:1989-01-01 00:00:00

  • Application of a radioreceptor assay in a pharmacokinetic study of oxitropium bromide in healthy volunteers after single i.v., oral and inhalation doses.

    abstract::Oxitropium bromide (OXBR) is a new anticholinergic drug, which is expected to be useful in the treatment of nocturnal asthma. The only pharmacokinetic data were obtained with the 14C-labelled compound. A sensitive radioreceptor assay for the determination of unlabelled OXBR in plasma was developed, based on competitio...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00558132

    authors: Ensing K,de Zeeuw RA,in 't Hout WG,Cornelissen PJ

    更新日期:1989-01-01 00:00:00

  • Population pharmacokinetics of intravenous ondansetron in oncology and surgical patients aged 1-48 months.

    abstract:PURPOSE:Until recently, ondansetron was approved for the prevention of nausea and vomiting only in patients older than 2 years. However, as the use of ondansetron in patients younger than 2 years had been documented, characterization of ondansetron pharmacokinetics in this younger pediatric age group was warranted. ME...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章,多中心研究

    doi:10.1007/s00228-009-0730-8

    authors: Mondick JT,Johnson BM,Haberer LJ,Sale ME,Adamson PC,Coté CJ,Croop JM,Russo MW,Barrett JS,Hoke JF

    更新日期:2010-01-01 00:00:00

  • A comparative study of the effects of aspirin and paracetamol (acetaminophen) on platelet aggregation and bleeding time.

    abstract::In a double blind, randomised trial, the effects of 1 g aspirin and 1 g paracetamol were compared on bleeding time and platelet aggregation in 40 volunteers (20 females). Also investigated was the relationship between plasma aspirin esterase activity and both bleeding time and platelet aggregation after aspirin. Follo...

    journal_title:European journal of clinical pharmacology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/BF00543486

    authors: Seymour RA,Williams FM,Oxley A,Ward A,Fearns M,Brighan K,Rawlins MD,Jones PM

    更新日期:1984-01-01 00:00:00

  • Drug interactions between tacrolimus and clotrimazole troche: a data mining approach followed by a pharmacokinetic study.

    abstract:PURPOSE:This study investigated the effects of clotrimazole troche on the risk of transplant rejection and the pharmacokinetics of tacrolimus. METHODS:The data mining approach was used to investigate whether the use of clotrimazole increased the risk of transplant rejection in patients receiving tacrolimus therapy. Pa...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-019-02770-6

    authors: Uno T,Wada K,Hosomi K,Matsuda S,Ikura MM,Takenaka H,Terakawa N,Oita A,Yokoyama S,Kawase A,Takada M

    更新日期:2020-01-01 00:00:00

  • Aspirin in people with dementia, long-term benefits, and harms: a systematic review.

    abstract:PURPOSE:People with dementia may have indications for aspirin prescription and clinicians are asked to balance the potential risks against benefits. This review examines the evidence for the risk and benefit of long-term aspirin use in people with dementia aged over 65 years, including randomised controlled trials and ...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章,评审

    doi:10.1007/s00228-021-03089-x

    authors: Davis KAS,Bishara D,Molokhia M,Mueller C,Perera G,Stewart RJ

    更新日期:2021-01-22 00:00:00

  • Role of active metabolites in the use of opioids.

    abstract::The opioid class of drugs, a large group, is mainly used for the treatment of acute and chronic persistent pain. All are eliminated from the body via metabolism involving principally CYP3A4 and the highly polymorphic CYP2D6, which markedly affects the drug's function, and by conjugation reactions mainly by UGT2B7. In ...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章,评审

    doi:10.1007/s00228-008-0570-y

    authors: Coller JK,Christrup LL,Somogyi AA

    更新日期:2009-02-01 00:00:00

  • The pharmacokinetics of carbamazepine.

    abstract::The time-courses of plasma carbamazepine concentrations were followed in six apparently healthy adult subjects who, at different times, took single oral drug doses of 200, 400, 500, 600, 700, 800 and 900 mg. There were some suggestions of impaired bioavailability of the drug when given in tablet form. The following va...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00561065

    authors: Cotter LM,Eadie MJ,Hooper WD,Lander CM,Smith GA,Tyrer JH

    更新日期:1977-12-28 00:00:00

  • Quality and impact of problem-oriented drug information: a method to change clinical practice among physicians?

    abstract:OBJECTIVES:Problem-oriented drug information is characterised by health professionals actively seeking drug information through various sources. In this study our objective was to determine the quality and impact of problem-oriented drug information among physicians. METHODS:Evaluation forms accompanying 163 written a...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/s00228-001-0386-5

    authors: Schjøtt J,Pomp E,Gedde-Dahl A

    更新日期:2002-02-01 00:00:00

  • Effect of probenecid on isofezolac kinetics.

    abstract::The interaction between isofezolac and probenecid has been studied with the aid of a specific HPLC assay for isofezolac in plasma and urine. 8 healthy adult volunteers received a single 40 mg oral dose of isofezolac before and after 3 days of loading with 0.5 probenecid t.i.d. There was an increase in the maximum plas...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00544363

    authors: Bannier A,Comet F,Soubeyrand J,Brazier JL,Chauliac F

    更新日期:1985-01-01 00:00:00

  • Effect of diuretics and calcium antagonists on circulatory parameters and plasma catecholamines during mental stress.

    abstract::In a model of mental stress the influence of nifedipine and hydrochlorothiazide on stress-induced changes in blood pressure, heart rate, and plasma catecholamines was studied in normal persons. The drugs were used to investigate whether substances with antihypertensive but no particular sympatholytic properties were c...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00544008

    authors: Heidbreder E,Schafferhans K,Kirsten R,Heidland A

    更新日期:1983-01-01 00:00:00

  • Pharmacokinetics and metabolism of quinidine in extensive and poor metabolisers of sparteine.

    abstract::The pharmacokinetics and metabolism of quinidine were investigated in extensive and poor metabolisers of sparteine. No differences in plasma clearance, terminal half life, volume of distribution or cumulative urinary excretion of quinidine, 3-hydroxyquinidine and quinidine-N-oxide were observed between phenotypes. Thu...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:10.1007/BF00870989

    authors: Mikus G,Ha HR,Vozeh S,Zekorn C,Follath F,Eichelbaum M

    更新日期:1986-01-01 00:00:00

  • Pharmacokinetics of the selective benzodiazepine antagonist Ro 15-1788 in man.

    abstract::The pharmacokinetics of the selective benzodiazepine antagonist Ro 15-1788 has been studied in 6 healthy male volunteers following a single intravenous dose of 2.5 mg. The drug was only slightly bound to plasma proteins (40 +/- 8%, mean +/- SD). A negligible amount (less than 0.2% of the dose) of unchanged drug was re...

    journal_title:European journal of clinical pharmacology

    pub_type: 杂志文章

    doi:

    authors: Klotz U,Ziegler G,Reimann IW

    更新日期:1984-01-01 00:00:00